| Female Reproductive System Neoplasm studied in …STUDIED_INderived200 of 6,382show all (up to 200) |
|---|
| → studied in | NCT01242072Phase 1 · completed Intravenous Palifosfamide-tris in Combination With Etoposide and Carboplatin in Patients With Malignancies · condition mapped CURATED_EXACT · 6,382 trials mapped (1,872 active) | — | — | Malignant Ovarian Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02345265Phase 2 · active not recruiting Testing the Combination of the Study Drugs Cediranib and Olaparib in Recurrent Ovarian Cancer · condition mapped ONTOLOGY_EXACT · 6,382 trials mapped (1,872 active) | — | — | Fallopian Tube Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02446600Phase 3 · active not recruiting Testing the Use of A Single Drug (Olaparib) or the Combination of Two Drugs (Cediranib and Olaparib) Compared to the Usual Chemotherapy for Women With Platinum Sensitive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer · condition mapped ONTOLOGY_EXACT · 6,382 trials mapped (1,872 active) | — | — | Fallopian Tube Clear Cell Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02465060Phase 2 · active not recruiting Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial) · condition mapped ONTOLOGY_EXACT · 6,382 trials mapped (1,872 active) | — | — | Cervical Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02502266Phase 2/Phase 3 · active not recruiting Testing the Combination of Cediranib and Olaparib in Comparison to Each Drug Alone or Other Chemotherapy in Recurrent Platinum-Resistant Ovarian Cancer · condition mapped ONTOLOGY_EXACT · 6,382 trials mapped (1,872 active) | — | — | Fallopian Tube Clear Cell Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03348631Phase 2 · active not recruiting Tazemetostat in Treating Patients With Recurrent Ovarian or Endometrial Cancer · condition mapped CURATED_BROADER · 6,382 trials mapped (1,872 active) | — | — | Malignant Uterine Corpus Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05051722recruiting Leveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer, Ovarian Cancer, and Cervical Cancer · condition mapped CURATED_BROADER · 6,382 trials mapped (1,872 active) | — | — | Malignant Endometrial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05242770NA · completed Pelvic Physical Therapy for Sexual Dysfunction in Gynecologic Oncology Survivors · condition mapped ALIAS · 6,382 trials mapped (1,872 active) | — | — | Malignant Female Reproductive System Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05256225Phase 3 · recruiting Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or Carcinosarcoma · condition mapped ONTOLOGY_EXACT · 6,382 trials mapped (1,872 active) | — | — | Endometrial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05287451NA · recruiting Risk Reducing Salpingectomy With Delayed Oophorectomy as an Alternative to Risk- Reducing Salpingo-oophorectomy in High Risk-Women to Assess the Safety of Prevention - US Cohort Study · condition mapped CURATED_EXACT · 6,382 trials mapped (1,872 active) | — | — | Malignant Ovarian Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05564377Phase 2 · recruiting Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial · condition mapped ONTOLOGY_EXACT · 6,382 trials mapped (1,872 active) | — | — | Malignant Female Reproductive System Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05877599Phase 1 · recruiting A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation · condition mapped CURATED_EXACT · 6,382 trials mapped (1,872 active) | — | — | Malignant Ovarian Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05891171Phase 1 · active not recruiting Study of AB598 Monotherapy and Combination Therapy in Participants With Advanced Cancers · condition mapped CURATED_EXACT · 6,382 trials mapped (1,872 active) | — | — | Malignant Cervical Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06498661NA · active not recruiting Self-collection for HPV Testing to Improve Cervical Cancer Prevention (SHIP) Trial (LMI-001-A-S01) · condition mapped ONTOLOGY_EXACT · 6,382 trials mapped (1,872 active) | — | — | Cervical Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06799065Phase 1/Phase 2 · recruiting First-in-Human Study of ATX-295, an Oral Inhibitor of KIF18A, as Monotherapy and in Combination With Anticancer Therapy in Patients With Advanced or Metastatic Solid Tumors, Including Ovarian Cancer · condition mapped CURATED_EXACT · 6,382 trials mapped (1,872 active) | — | — | Malignant Ovarian Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06888921Phase 1/Phase 2 · recruiting A Clinical Trial to Evaluate the Safety and Efficacy of COM701 in Relapsed Platinum Sensitive Ovarian Cancer · condition mapped CURATED_EXACT · 6,382 trials mapped (1,872 active) | — | — | Malignant Ovarian Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06890338Phase 2 · recruiting A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer. · condition mapped ALIAS · 6,382 trials mapped (1,872 active) | — | — | Malignant Fallopian Tube Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07061977Phase 3 · recruiting Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation and Pembrolizumab Maintenance Compared to Standard Chemoradiation With Pembrolizumab Followed by Pembrolizumab Maintenance in High-Risk Cervical Cancer · condition mapped CURATED_BROADER · 6,382 trials mapped (1,872 active) | — | — | Cervical Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07167069completed India HIV-CervCa Project · condition mapped CURATED_EXACT · 6,382 trials mapped (1,872 active) | — | — | Malignant Cervical Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07198074Phase 3 · recruiting Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer · condition mapped CURATED_BROADER · 6,382 trials mapped (1,872 active) | — | — | Endometrial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07278336Phase 1 · recruiting A Study to Assess Adverse Events, Change in Disease Activity and How Intravenous (IV) ABBV901 Moves Through the Body Alone or in Combination With Other Anticancer Drugs in Adult Participants With Ovarian Cancer · condition mapped CURATED_EXACT · 6,382 trials mapped (1,872 active) | — | — | Malignant Ovarian Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07402915Phase 1 · recruiting Drug-drug Interaction Study With AZD5335 and Itraconazole in Participants With Ovarian, Primary Peritoneal, or Fallopian Tube Cancer · condition mapped ALIAS · 6,382 trials mapped (1,872 active) | — | — | Malignant Fallopian Tube Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07504588Phase 2 · recruiting Sacituzumab Govitecan With Bevacizumab Compared to Usual Chemotherapy (Carboplatin, Pegylated Liposomal Doxorubicin and Bevacizumab) for Treating Recurrent Platinum-Sensitive Ovarian Cancer After PARP Inhibitor Maintenance Therapy · condition mapped CURATED_BROADER · 6,382 trials mapped (1,872 active) | — | — | Platinum-Sensitive Fallopian Tube Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07705035Phase 1 · recruiting DBC-664 in Adult Patients With Solid Tumors · condition mapped ONTOLOGY_EXACT · 6,382 trials mapped (1,872 active) | — | — | Ovarian Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07809659NA · recruiting CanRisk-Based Ovarian Cancer Risk Assessment Versus Standard Practice (DISARM CSA) · condition mapped CURATED_EXACT · 6,382 trials mapped (1,872 active) | — | — | Malignant Ovarian Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07848243Phase 2 · recruiting Clinical Investigator-Initiated Trial (IIT) of PD-L1-Targeted Radionuclide Probes · condition mapped ALIAS · 6,382 trials mapped (1,872 active) | — | — | Cervical Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00043472completed Removal of the Ovaries/Fallopian Tubes and CA-125 Screening to Reduce the Risk of Ovarian Cancer in Women at Increased Genetic Risk · condition mapped CURATED_EXACT · 6,382 trials mapped (1,872 active) | — | — | Malignant Ovarian Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01247597recruiting DICER1-related Pleuropulmonary Blastoma Cancer Predisposition Syndrome: A Natural History Study · condition mapped ONTOLOGY_EXACT · 6,382 trials mapped (1,872 active) | — | — | Ovarian Sertoli-Leydig Cell Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01441089recruiting Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis · condition mapped CURATED_EXACT · 6,382 trials mapped (1,872 active) | — | — | Malignant Ovarian Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03412877Phase 2 · recruiting Administration of Autologous T-Cells Genetically Engineered to Express T-Cell Receptors Reactive Against Neoantigens in People With Metastatic Cancer · condition mapped CURATED_EXACT · 6,382 trials mapped (1,872 active) | — | — | Malignant Ovarian Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03668340Phase 2 · active not recruiting AZD1775 in Women With Recurrent or Persistent Uterine Serous Carcinoma or Uterine Carcinosarcoma · condition mapped ALIAS · 6,382 trials mapped (1,872 active) | — | — | Malignant Uterine Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03762733enrolling by invitation Tissue Acquisition and Genomics Analysis of Breast Cancer and Other Gynecologic Malignancies · condition mapped CURATED_EXACT · 6,382 trials mapped (1,872 active) | — | — | Malignant Ovarian Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04065009Phase 3 · active not recruiting The IPLA-OVCA Trial, Intra-Peritoneal Local Anaesthetics in Ovarian Cancer · condition mapped CURATED_BROADER · 6,382 trials mapped (1,872 active) | — | — | Malignant Ovarian Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04789694Phase 3 · recruiting Prehabilitation in Gynaecological Cancer Patients · condition mapped CURATED_EXACT · 6,382 trials mapped (1,872 active) | — | — | Malignant Ovarian Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05007106Phase 2 · completed MK-7684A With or Without Other Anticancer Therapies in Participants With Selected Solid Tumors (MK-7684A-005) (KEYVIBE-005) · condition mapped ONTOLOGY_EXACT · 6,382 trials mapped (1,872 active) | — | — | Endometrial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05112601Phase 2 · recruiting Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma · condition mapped ONTOLOGY_EXACT · 6,382 trials mapped (1,872 active) | — | — | Endometrial Clear Cell Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05867251Phase 1/Phase 2 · recruiting Study of AVZO-021 in Patients With Advanced Solid Tumors · condition mapped ALIAS · 6,382 trials mapped (1,872 active) | — | — | Malignant Fallopian Tube Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05932212Phase 2 · terminated AK104 for Recurrent or Metastatic Vulvar Cancer · condition mapped CURATED_EXACT · 6,382 trials mapped (1,872 active) | — | — | Malignant Vulvar Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05956093NA · active not recruiting 68Ga-FAPI PET/CT in the Staging of High-Grade Epithelial Ovarian Cancers: A Pilot Study · condition mapped ONTOLOGY_EXACT · 6,382 trials mapped (1,872 active) | — | — | High-Grade Serous Ovarian Cancer | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06298877NA · recruiting Frailty, Quality Of Life and Early Reversal of Temporary Defunctioning Stoma in Ovarian Cancer · condition mapped CURATED_EXACT · 6,382 trials mapped (1,872 active) | — | — | Malignant Ovarian Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06586957Phase 1 · recruiting A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors · condition mapped CURATED_EXACT · 6,382 trials mapped (1,872 active) | — | — | Malignant Ovarian Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06619236Phase 3 · active not recruiting Study to Assess the Efficacy of Rina-S Compared to Treatment of Investigator's Choice in Participants With Platinum Resistant Ovarian Cancer · condition mapped ALIAS · 6,382 trials mapped (1,872 active) | — | — | Platinum-Resistant Ovarian Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07078838Phase 2 · not yet recruiting Tirzepatide in Women With Obesity and Endometrial Intra-epithelial Neoplasia or Grade 1 Endometrial Cancer · condition mapped CURATED_BROADER · 6,382 trials mapped (1,872 active) | — | — | Malignant Endometrial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07578649Phase 3 · not yet recruiting Symbiotic-GYN-18: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Advanced or Recurrent MMR-proficient Endometrial Cancer · condition mapped ONTOLOGY_EXACT · 6,382 trials mapped (1,872 active) | — | — | Endometrial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07843303Phase 2 · not yet recruiting Trastuzumab Rezetecan Plus Bevacizumab in Platinum-Sensitive Recurrent Ovarian Cancer: A Phase II,Multicenter, Single-Arm Study · condition mapped CURATED_EXACT · 6,382 trials mapped (1,872 active) | — | — | Malignant Ovarian Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03108495Phase 2 · terminated Study of LN-145, Autologous Tumor Infiltrating Lymphocytes in the Treatment of Patients With Cervical Carcinoma · condition mapped ONTOLOGY_EXACT · 6,382 trials mapped (1,872 active) | — | — | Cervical Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03564340Phase 1/Phase 2 · recruiting Study of REGN4018 (Ubamatamab) Administered Alone or in Combination With Cemiplimab in Adult Patients With Recurrent Ovarian Cancer or Other Recurrent Mucin-16 Expressing (MUC16+) Cancers · condition mapped CURATED_BROADER · 6,382 trials mapped (1,872 active) | — | — | Malignant Ovarian Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03702309recruiting Liquid Biopsy Evaluation and Repository Development at Princess Margaret · condition mapped CURATED_EXACT · 6,382 trials mapped (1,872 active) | — | — | Malignant Ovarian Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04945187NA · completed Patient-Reported Outcomes Among Women Wtih Gynecological Cancer (The CONNECT Study) · condition mapped ALIAS · 6,382 trials mapped (1,872 active) | — | — | Female Reproductive System Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04981119recruiting Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing · condition mapped CURATED_EXACT · 6,382 trials mapped (1,872 active) | — | — | Malignant Ovarian Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05257408Phase 3 · active not recruiting Relacorilant in Combination With Nab-Paclitaxel in Advanced, Platinum-Resistant, High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian-Tube Cancer · condition mapped ONTOLOGY_EXACT · 6,382 trials mapped (1,872 active) | — | — | Fallopian Tube Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05715216Phase 2 · active not recruiting EON: A Single-arm Phase II Study of Etigilimab (OMP-313M32) in Combination With Checkpoint Inhibition (Nivolumab) in Patients With Platinum-resistant, Recurrent Epithelial Ovarian Cancer · condition mapped CURATED_EXACT · 6,382 trials mapped (1,872 active) | — | — | Malignant Ovarian Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05922930Phase 1/Phase 2 · active not recruiting Study of TROP2 CAR Engineered IL15-transduced Cord Blood-derived NK Cells Delivered Intraperitoneally for the Management of Platinum Resistant Ovarian Cancer, Mesonephric-like Adenocarcinoma, and Pancreatic Cancer · condition mapped CURATED_EXACT · 6,382 trials mapped (1,872 active) | — | — | Malignant Ovarian Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06172478Phase 2 · recruiting A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors · condition mapped CURATED_EXACT · 6,382 trials mapped (1,872 active) | — | — | Malignant Cervical Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06218914Phase 1 · recruiting Phase 1 Study to Investigate TCRTs KRAS Mutation in Unresectable, Advanced, and/or Metastatic Solid Tumors · condition mapped CURATED_BROADER · 6,382 trials mapped (1,872 active) | — | — | Malignant Endometrial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06855524Phase 2 · recruiting Fucoidan for Preventing Chemotherapy-Related Fatigue in Patients With Gastrointestinal, Gynecological, Breast, or Lung Cancer · condition mapped ONTOLOGY_EXACT · 6,382 trials mapped (1,872 active) | — | — | Malignant Female Reproductive System Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06952660Phase 4 · recruiting Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical Cancer · condition mapped CURATED_EXACT · 6,382 trials mapped (1,872 active) | — | — | Malignant Cervical Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07124000recruiting DESTINY-PANTUMOUR04 · condition mapped CURATED_EXACT · 6,382 trials mapped (1,872 active) | — | — | Malignant Cervical Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07216703Phase 3 · recruiting A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintenance Treatment of Cervical Cancer (MK-2870-036/TroFuse-036/GOG-3123/ENGOT-cx22) · condition mapped CURATED_EXACT · 6,382 trials mapped (1,872 active) | — | — | Malignant Cervical Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07270666NA · recruiting ctDNA Testing to Inform Standard-of-Care Treatment Decisions in People With Endometrial Cancer · condition mapped CURATED_BROADER · 6,382 trials mapped (1,872 active) | — | — | Malignant Endometrial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07435987NA · recruiting Clinical Feasibility of the ARCHITECT Applicator in Cervical Cancer Brachytherapy · condition mapped CURATED_BROADER · 6,382 trials mapped (1,872 active) | — | — | Malignant Cervical Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07508358Phase 1 · not yet recruiting Vaginal Sildenafil for Primary Dysmenorrhea · condition mapped ALIAS · 6,382 trials mapped (1,872 active) | — | — | Uterine Corpus Leiomyoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07670312Phase 1/Phase 2 · recruiting Evaluation of XYA02 in Patients With Advanced Solid Tumors · condition mapped CURATED_EXACT · 6,382 trials mapped (1,872 active) | — | — | Malignant Ovarian Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04590326Phase 1/Phase 2 · recruiting A Study to Find Out How Safe REGN5668 is and How Well it Works In Adult Women When Given With Either Cemiplimab, or Cemiplimab + Fianlimab, or Ubamatamab · condition mapped CURATED_EXACT · 6,382 trials mapped (1,872 active) | — | — | Malignant Ovarian Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05640999Phase 2 · recruiting Adjuvant Therapy in POLE-Mutated and p53-Wildtype/NSMP Early Stage Endometrial Cancer RAINBO BLUE & TAPER · condition mapped CURATED_BROADER · 6,382 trials mapped (1,872 active) | — | — | Malignant Endometrial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06047379Phase 1/Phase 2 · recruiting Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis · condition mapped CURATED_EXACT · 6,382 trials mapped (1,872 active) | — | — | Malignant Cervical Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06553612NA · recruiting Impact of a Multidisciplinary Assessment in Day Hospitalization Versus Standard Care on the Deployment of Supportive Oncology Care Recommended by the Personalized Post-cancer Plan in Patients at the End of Initial Treatment for Gynecological Ovarian and Endometrial Cancer Endometrial Cancer · condition mapped ALIAS · 6,382 trials mapped (1,872 active) | — | — | Malignant Female Reproductive System Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07594015Phase 2 · recruiting Pembrolizumab and Lenvatinib in Mismatch Repair Proficient Recurrent Endometrial Cancer After Progression on or Following First-Line Immunotherapy Maintenance · condition mapped CURATED_BROADER · 6,382 trials mapped (1,872 active) | — | — | Malignant Endometrial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07776691Phase 3 · recruiting A Study of Raludotatug Deruxtecan With or Without Bevacizumab as First-Line Maintenance Treatment in Non-HRD-Positive Advanced Ovarian Cancer (MK-5909-006, (ENGOT-ov102/GOG-3141/ REJOICE-Ovarian 04) · condition mapped CURATED_EXACT · 6,382 trials mapped (1,872 active) | — | — | Malignant Ovarian Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07838207recruiting Prognosis and Therapeutic Implications in Molecular High-Risk Non-Myoinvasive Endometrial Cancer · condition mapped CURATED_BROADER · 6,382 trials mapped (1,872 active) | — | — | Malignant Endometrial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04044859Phase 1 · active not recruiting ADP-A2M4CD8 as Monotherapy or in Combination With Either Nivolumab or Pembrolizumab in HLA-A2+ Subjects With MAGE-A4 Positive Tumors (SURPASS) · condition mapped CURATED_BROADER · 6,382 trials mapped (1,872 active) | — | — | Malignant Endometrial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04145518Phase 4 · completed Mechanistic Characterization of Uterine Pain · condition mapped ALIAS · 6,382 trials mapped (1,872 active) | — | — | Uterine Corpus Leiomyoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04212910completed Stratifying Endometrial Cancer Patients Using a PET/MRI Prognostic Model · condition mapped ONTOLOGY_EXACT · 6,382 trials mapped (1,872 active) | — | — | Endometrial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05489211Phase 2 · recruiting Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03) · condition mapped CURATED_BROADER · 6,382 trials mapped (1,872 active) | — | — | Malignant Endometrial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06126276Phase 2 · recruiting Testing the Use of Neratinib or the Combination of Neratinib and Palbociclib Targeted Treatment for HER2+ Solid Tumors (A ComboMATCH Treatment Trial) · condition mapped ONTOLOGY_EXACT · 6,382 trials mapped (1,872 active) | — | — | Malignant Female Reproductive System Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06253520Phase 1 · active not recruiting Autologous T-cells Genetically Engineered to Express Receptors Reactive Against KRAS Mutations in Conjunction With a Vaccine Directed Against These Antigens in Participants With Metastatic Cancer · condition mapped CURATED_EXACT · 6,382 trials mapped (1,872 active) | — | — | Malignant Ovarian Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07708753Phase 3 · recruiting A Study of SYS6043 in Platinum-Resistant, Advanced Ovarian, Primary Peritoneal, or Fallopian Tube Cancers · condition mapped ALIAS · 6,382 trials mapped (1,872 active) | — | — | Platinum-Resistant Ovarian Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07806396NA · completed Effect of AI-Supported Virtual Patient Chatbot Training on Nursing Students' Self-Perceived Clinical Decision-Making and Gynecological Cancer Knowledge · condition mapped ALIAS · 6,382 trials mapped (1,872 active) | — | — | Malignant Female Reproductive System Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01174121Phase 2 · recruiting Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Cancer · condition mapped CURATED_BROADER · 6,382 trials mapped (1,872 active) | — | — | Malignant Ovarian Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03425565Phase 2 · completed A Study of Pembrolizumab in Patients With Advanced Gynaecological Clear Cell Cancer · condition mapped ALIAS · 6,382 trials mapped (1,872 active) | — | — | Malignant Female Reproductive System Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04266093enrolling by invitation Gene Therapy Follow up Protocol for Subjects Previously Enrolled in NCI Center for Immuno-Oncology Studies · condition mapped ONTOLOGY_EXACT · 6,382 trials mapped (1,872 active) | — | — | Cervical Intraepithelial Neoplasia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04708470Phase 1/Phase 2 · completed A Phase I/II Study of Combination Immunotherapy for Advanced Cancers Including HPV-Associated Malignancies, Small Bowel, and Colon Cancers · condition mapped CURATED_EXACT · 6,382 trials mapped (1,872 active) | — | — | Malignant Cervical Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05276973Phase 1 · active not recruiting Testing the Addition of Ipatasertib to the Usual Chemotherapy Treatment (Paclitaxel and Carboplatin) for Stage III or IV Epithelial Ovarian Cancer · condition mapped ONTOLOGY_EXACT · 6,382 trials mapped (1,872 active) | — | — | Fallopian Tube Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05446298Phase 2 · active not recruiting ONC-392 and Pembrolizumab in Platinum Resistant Ovarian Cancer · condition mapped CURATED_EXACT · 6,382 trials mapped (1,872 active) | — | — | Malignant Ovarian Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06714617Phase 1 · terminated Evaluate BL-M17D1 in Patients w/HER2-Expressing/Mutant Advanced or Metastatic Solid Tumors · condition mapped ONTOLOGY_EXACT · 6,382 trials mapped (1,872 active) | — | — | Endometrial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06814496Phase 1/Phase 2 · recruiting Radiation Combined With BIspecific T-Cell Engager in DLL3 Expressing Tumors · condition mapped CURATED_EXACT · 6,382 trials mapped (1,872 active) | — | — | Malignant Cervical Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07006727Phase 1 · recruiting Phase I Study of [225Ac]Ac-ETN029 in Patients With Advanced DLL3-expressing Solid Tumors · condition mapped ONTOLOGY_EXACT · 6,382 trials mapped (1,872 active) | — | — | Cervical Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07059845Phase 2 · recruiting A Study to Assess Adverse Events and Change in Disease Activity of Multiple Treatment Combinations With Intravenous Mirvetuximab Soravtansine in Adult Participants With Ovarian Cancer · condition mapped CURATED_EXACT · 6,382 trials mapped (1,872 active) | — | — | Malignant Ovarian Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07114601Phase 1 · recruiting A Study of LY4257496 in Participants With Cancer (OMNIRAY) · condition mapped ONTOLOGY_EXACT · 6,382 trials mapped (1,872 active) | — | — | Endometrial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07213804Phase 3 · recruiting A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer · condition mapped ONTOLOGY_EXACT · 6,382 trials mapped (1,872 active) | — | — | Fallopian Tube Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07262619Phase 1/Phase 2 · recruiting EIK1005-002: A Clinical Research Study Evaluating EIK1005, a Werner Helicase Inhibitor, as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors Including Microsatellite Instability High (MSI-H) Tumors · condition mapped CURATED_BROADER · 6,382 trials mapped (1,872 active) | — | — | Malignant Endometrial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07265739Phase 2 · not yet recruiting Losartan and Paclitaxel in Platinum Resistant Ovarian Cancer · condition mapped ALIAS · 6,382 trials mapped (1,872 active) | — | — | Platinum-Resistant Ovarian Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07620795NA · not yet recruiting Effect of Web-Based Education on Attitudes and Beliefs About HPV Testing · condition mapped CURATED_EXACT · 6,382 trials mapped (1,872 active) | — | — | Malignant Cervical Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07833852enrolling by invitation Long-Term Immune Persistence After Bivalent HPV Vaccination in Females From Study 311-HPV-1005 · condition mapped ONTOLOGY_EXACT · 6,382 trials mapped (1,872 active) | — | — | Cervical Intraepithelial Neoplasia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04512209NA · completed Characterization of Biophysical Stromal Properties in Human Cancer: Towards Personalized Computational Oncology · condition mapped CURATED_EXACT · 6,382 trials mapped (1,872 active) | — | — | Malignant Ovarian Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04644068Phase 1/Phase 2 · active not recruiting Study of AZD5305 as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Malignancies · condition mapped CURATED_EXACT · 6,382 trials mapped (1,872 active) | — | — | Malignant Ovarian Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05920798Phase 1/Phase 2 · active not recruiting Vaccine Therapy Plus Pembrolizumab in Treating Advanced Ovarian, Fallopian Tube, or Primary Peritoneal Cavity Cancer · condition mapped ALIAS · 6,382 trials mapped (1,872 active) | — | — | Fallopian Tube Malignant Mixed Mesodermal (Mullerian) Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05983432Phase 1 · recruiting Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors · condition mapped CURATED_EXACT · 6,382 trials mapped (1,872 active) | — | — | Malignant Ovarian Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06038032NA · recruiting ImpRoving hEalth behaviourS for LIfe After ENdometrial CancEr Trial · condition mapped CURATED_BROADER · 6,382 trials mapped (1,872 active) | — | — | Malignant Endometrial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06925724Phase 2 · recruiting A Study of Ivonescimab in People With Endometrial and Cervical Cancers · condition mapped CURATED_BROADER · 6,382 trials mapped (1,872 active) | — | — | Malignant Endometrial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07495124Phase 2 · recruiting IGFBP-2 Vaccine to Prevent Ovarian Cancer Progression in Patients With Serologic Detection of Recurrence · condition mapped ONTOLOGY_EXACT · 6,382 trials mapped (1,872 active) | — | — | Fallopian Tube Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07638410NA · recruiting Prehabilitation in High-risk Oncologic Surgery · condition mapped CURATED_EXACT · 6,382 trials mapped (1,872 active) | — | — | Malignant Ovarian Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07831902Phase 3 · recruiting Refining Adjuvant Treatment IN Endometrial Cancer Based On Molecular Features (RAINBO) - NSMP-ORANGE Trial: Comparing Radiotherapy With Oral Progestin Tablets vs. the Current Standard Care, Radiotherapy and Chemotherapy, in Patients With NSMP Endometrial Cancer · condition mapped CURATED_BROADER · 6,382 trials mapped (1,872 active) | — | — | Malignant Endometrial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07832227Phase 2 · not yet recruiting Imlunestrant/Abemaciclib/Selinexor in Ovarian and Endometrial · condition mapped ALIAS · 6,382 trials mapped (1,872 active) | — | — | Ovarian Low Grade Serous Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00515372Phase 1 · active not recruiting Depression Treatment and Screening in Ovarian Cancer Patients · condition mapped CURATED_EXACT · 6,382 trials mapped (1,872 active) | — | — | Malignant Ovarian Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03943316recruiting Prospective Laboratory Study Biologic Specimens and Tumor Tissue of Patients With Cancer · condition mapped CURATED_EXACT · 6,382 trials mapped (1,872 active) | — | — | Malignant Ovarian Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04038619Phase 1 · recruiting Fecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genitourinary Cancer Patients · condition mapped CURATED_EXACT · 6,382 trials mapped (1,872 active) | — | — | Malignant Ovarian Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04266886NA · active not recruiting Self-Hypnosis for the Enhanced Recovery After Surgery in Patients With Gynecologic Cancer · condition mapped ONTOLOGY_EXACT · 6,382 trials mapped (1,872 active) | — | — | Malignant Female Reproductive System Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04516135Phase 2 · active not recruiting Single Fraction or Multi-fraction Palliative Radiation Therapy for the Improvement of Quality of Life in Patients With Metastatic Gynecologic Cancers · condition mapped CURATED_BROADER · 6,382 trials mapped (1,872 active) | — | — | Malignant Female Reproductive System Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04614051Phase 1 · terminated A Phase 1 Study of Cellgram-DC in Patients With Advanced or Recurrent Epithelial Ovarian Cancer · condition mapped CURATED_EXACT · 6,382 trials mapped (1,872 active) | — | — | Malignant Ovarian Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04634877Phase 3 · active not recruiting Study of Pembrolizumab (MK-3475) in Combination With Adjuvant Chemotherapy With or Without Radiotherapy in Participants With Newly Diagnosed Endometrial Cancer After Surgery With Curative Intent (MK-3475-B21 / KEYNOTE-B21 / ENGOT-en11 / GOG-3053) · condition mapped ONTOLOGY_EXACT · 6,382 trials mapped (1,872 active) | — | — | Endometrial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04752826Phase 1/Phase 2 · recruiting BI-1808 as a Single Agent and With Pembrolizumab (KEYTRUDA® ) in Treatment of Advanced Malignancies(Keynote-D20) · condition mapped CURATED_EXACT · 6,382 trials mapped (1,872 active) | — | — | Malignant Ovarian Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05971303completed Impact of Cultural and Linguistic Backgrounds on Patient Care and Experience of Women With Gynecologic Malignancies · condition mapped ALIAS · 6,382 trials mapped (1,872 active) | — | — | Malignant Female Reproductive System Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06714084NA · enrolling by invitation CNCMT：a Multi-center, Prospective, Single-arm Study · condition mapped CURATED_BROADER · 6,382 trials mapped (1,872 active) | — | — | Malignant Cervical Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07147361active not recruiting Predictive Biomarkers for PD-1 Inhibitor Response in Squamous Cell Carcinoma · condition mapped CURATED_BROADER · 6,382 trials mapped (1,872 active) | — | — | Cervical Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07465133not yet recruiting Updating the EORTC Quality-of-Life Questionnaire for Ovarian Cancer (QLQ-OV38) · condition mapped CURATED_EXACT · 6,382 trials mapped (1,872 active) | — | — | Malignant Ovarian Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07810920recruiting Artificial Intelligence Into Ultrasound Diagnostics in Reproductive Medicine · condition mapped ONTOLOGY_EXACT · 6,382 trials mapped (1,872 active) | — | — | Uterine Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02704832NA · completed Role of Geriatric Intervention in Treatment of Older Patients With Cancer (PREPARE) · condition mapped CURATED_EXACT · 6,382 trials mapped (1,872 active) | — | — | Malignant Ovarian Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04152499Phase 1/Phase 2 · active not recruiting Phase I-II, FIH, TROP2 ADC, Advanced Unresectable/Metastatic Solid Tumors, Refractory to Standard Therapies (KL264-01) · condition mapped ONTOLOGY_EXACT · 6,382 trials mapped (1,872 active) | — | — | Endometrial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05021237Phase 2 · completed Personalized Ultra-fractionated Stereotactic Adaptive Radiotherapy for Metastatic Cervical Cancer · condition mapped CURATED_EXACT · 6,382 trials mapped (1,872 active) | — | — | Malignant Cervical Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05316129Phase 1 · recruiting Infusion of Autologous T Cells Engineered to Target FSH Receptor in Recurrent Ovarian Cancer · condition mapped CURATED_EXACT · 6,382 trials mapped (1,872 active) | — | — | Malignant Ovarian Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05475171Phase 2 · recruiting Triage of Advanced Cervical Cancer Through Immunotherapy Induction (TRACTION) · condition mapped CURATED_EXACT · 6,382 trials mapped (1,872 active) | — | — | Malignant Cervical Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05758688Phase 2 · recruiting PROton Therapy for Post Surgical Treatment of GYNecologic Cancer · condition mapped CURATED_EXACT · 6,382 trials mapped (1,872 active) | — | — | Malignant Cervical Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06340568Phase 3 · recruiting A Clinical Study of the Anti-cancer Effects of an Investigational Therapy or Chemotherapy in Patients With Recurring Uterine Cancer · condition mapped CURATED_BROADER · 6,382 trials mapped (1,872 active) | — | — | Malignant Endometrial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06952504Phase 3 · recruiting A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29) · condition mapped CURATED_BROADER · 6,382 trials mapped (1,872 active) | — | — | Malignant Endometrial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07020117Phase 1 · recruiting A Study of [225Ac]Ac-AKY-1189 in Patients With Solid Tumors · condition mapped CURATED_BROADER · 6,382 trials mapped (1,872 active) | — | — | Cervical Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07109726Phase 1/Phase 2 · recruiting A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations · condition mapped CURATED_BROADER · 6,382 trials mapped (1,872 active) | — | — | Malignant Endometrial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07318558Phase 3 · recruiting A Clinical Trial of Sac-TMT in People With Non-HRD Positive Advanced Ovarian Cancer (MK-2870-021) · condition mapped CURATED_EXACT · 6,382 trials mapped (1,872 active) | — | — | Malignant Ovarian Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07576725Phase 2 · not yet recruiting Low Dose, Reduced Frequency Nivolumab for the Treatment of Unresectable or Metastatic Cancer, AFFORD IO Trial · condition mapped CURATED_BROADER · 6,382 trials mapped (1,872 active) | — | — | Cervical Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04273061Phase 2 · recruiting Investigating the Effects of Atezolizumab in People Whose Tumour DNA or RNA Indicates Possible Sensitivity · condition mapped ALIAS · 6,382 trials mapped (1,872 active) | — | — | Malignant Female Reproductive System Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04604613active not recruiting Prediction of Recurrence Among Low Risk Endometrial Cancer Patients · condition mapped ONTOLOGY_EXACT · 6,382 trials mapped (1,872 active) | — | — | FIGO Grade 2 Endometrial Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05677048NA · active not recruiting Feasibility Study: IGNITE-TX (Identifying Individuals for Genetic Testing & Treatment) Intervention · condition mapped ALIAS · 6,382 trials mapped (1,872 active) | — | — | Malignant Female Reproductive System Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06366347Phase 2 · recruiting ALPINE: Maintenance Letrozole/Abemaciclib · condition mapped CURATED_BROADER · 6,382 trials mapped (1,872 active) | — | — | Malignant Endometrial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06409052recruiting Endometrial Cancer, Risk Factors and Prevention Strategies: Perspectives of Patients and At-Risk Women · condition mapped CURATED_BROADER · 6,382 trials mapped (1,872 active) | — | — | Malignant Endometrial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06873555Phase 1/Phase 2 · recruiting A Study of DC05F01 in Chinese Patients With Recurrent/Refractory Ovarian Cancer and Other Advanced Solid Tumors · condition mapped CURATED_EXACT · 6,382 trials mapped (1,872 active) | — | — | Malignant Ovarian Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07116213NA · recruiting Clinical Research on Moderately Hypofractionated Adaptive Postoperative Radiotherapy for High-Risk Endometrial Cancer · condition mapped CURATED_BROADER · 6,382 trials mapped (1,872 active) | — | — | Malignant Endometrial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07489287Phase 1 · recruiting GB-5267 for the Treatment Platinum-Resistant Ovarian, Peritoneal, or Fallopian Tube Cancer · condition mapped ALIAS · 6,382 trials mapped (1,872 active) | — | — | Platinum-Resistant Ovarian Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07584161NA · recruiting MH-ART vs CF-IMRT in Postoperative Cervical/Endometrial Cancer · condition mapped CURATED_EXACT · 6,382 trials mapped (1,872 active) | — | — | Malignant Cervical Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07718854Phase 2 · recruiting Sacituzumab Tirumotecan +/- Pembrolizumab in I/O Exposed Metastatic or Recurrent Ovarian Clear Cell Cancer · condition mapped CURATED_BROADER · 6,382 trials mapped (1,872 active) | — | — | Malignant Ovarian Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07821775completed Robotic vs Laparoscopic and Open Surgery for Abdominopelvic Cancers · condition mapped ONTOLOGY_EXACT · 6,382 trials mapped (1,872 active) | — | — | Endometrial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07821879recruiting Routine Shallow-coverage Whole Genome Sequencing Testing of Liquid-based Cervical Smears for the Early Diagnosis of Ovarian Cancer · condition mapped ONTOLOGY_EXACT · 6,382 trials mapped (1,872 active) | — | — | High-Grade Serous Ovarian Cancer | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07822646Phase 3 · recruiting A Phase 3 Study of Manganese-primed Immunochemotherapy in Patients With Advanced Ovarian Cancer · condition mapped CURATED_EXACT · 6,382 trials mapped (1,872 active) | — | — | Malignant Ovarian Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02598219Phase 3 · completed Evaluation of Sentinel Node Policy in Early Stage Endometrial Carcinomas at Intermediate and High Risk of Recurrence. · condition mapped ALIAS · 6,382 trials mapped (1,872 active) | — | — | Endometrioid Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03634267Phase 1 · terminated MRI-Guided Brachytherapy in Treating Participants With HPV-Associated Stage IB2-IVA Cervical or Stage II-IVA Vaginal Cancer · condition mapped CURATED_BROADER · 6,382 trials mapped (1,872 active) | — | — | Malignant Cervical Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04073706Phase 3 · recruiting Sentinel Node Biopsy in Endometrial Cancer · condition mapped CURATED_BROADER · 6,382 trials mapped (1,872 active) | — | — | Malignant Endometrial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04585750Phase 1/Phase 2 · recruiting The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE) · condition mapped CURATED_EXACT · 6,382 trials mapped (1,872 active) | — | — | Malignant Ovarian Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05080946early Phase 1 · suspended Using Aspirin to Improve Immunological Features of Ovarian Tumors · condition mapped CURATED_EXACT · 6,382 trials mapped (1,872 active) | — | — | Malignant Ovarian Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05739981Phase 1/Phase 2 · recruiting Phase II IMNN-001 (Also Known as GEN-1) on SLL With BEV and NACT, Newly Diagnosed Advanced Ovarian, Fallopian Tube or Primary Peritoneal Cancer · condition mapped CURATED_EXACT · 6,382 trials mapped (1,872 active) | — | — | Malignant Ovarian Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06412510Phase 1/Phase 2 · active not recruiting Prehabilitation for EOC, Fallopian Tube, Primary Peritoneal Carcinoma and Pancreatic Cancer w/ NACT · condition mapped CURATED_EXACT · 6,382 trials mapped (1,872 active) | — | — | Malignant Ovarian Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06633224recruiting Fatigue and Molecular Mechanisms in Cancer Patients Receiving CCRT · condition mapped ALIAS · 6,382 trials mapped (1,872 active) | — | — | Malignant Female Reproductive System Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06915025Phase 3 · recruiting Phase 3 Trial Evaluating the Safety & Efficacy of IMNN-001 Administered in Combination w/ Standard NACT & Adjuvant Chemotherapy in Newly Diagnosed Patients w/ Advanced EOC, Fallopian Tube or Primary Peritoneal Cancer · condition mapped CURATED_EXACT · 6,382 trials mapped (1,872 active) | — | — | Malignant Ovarian Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07023627Phase 2 · recruiting A Study of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression · condition mapped CURATED_EXACT · 6,382 trials mapped (1,872 active) | — | — | Malignant Ovarian Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07214779Phase 3 · recruiting Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression · condition mapped CURATED_EXACT · 6,382 trials mapped (1,872 active) | — | — | Malignant Ovarian Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07217171Phase 1 · recruiting A Study Evaluating the Safety, Efficacy, and Pharmacokinetics (PK) of EVOLVE104 in Participants With Advanced Urothelial and Squamous Cell Carcinomas · condition mapped CURATED_BROADER · 6,382 trials mapped (1,872 active) | — | — | Vulvar Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07259616completed Incidence of Cervical Cancer in HPV-positive Women With Low-grade Cytological Abnormalities · condition mapped ONTOLOGY_EXACT · 6,382 trials mapped (1,872 active) | — | — | Cervical Intraepithelial Neoplasia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07303894Phase 2 · recruiting A Study of Isoquercetin in People With Ovarian Cancer · condition mapped CURATED_EXACT · 6,382 trials mapped (1,872 active) | — | — | Malignant Ovarian Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07341737Phase 1/Phase 2 · recruiting SL-28 for Advanced Solid Tumours · condition mapped CURATED_EXACT · 6,382 trials mapped (1,872 active) | — | — | Malignant Ovarian Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07429487NA · recruiting Assessment of Adherence to Remotely Monitored Physical Activity Tracked on a Smartwatch, and Its Impact on Reducing Fatigue 3 Months After Adjuvant Chemotherapy for Cancer · condition mapped ONTOLOGY_EXACT · 6,382 trials mapped (1,872 active) | — | — | Ovarian Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07820358Phase 2 · not yet recruiting Semaglutide, Weight Loss, and LNG-IUD for Conservative Treatment of Endometrial Atypical Hyperplasia and Grade 1 Endometrial Cancer · condition mapped ONTOLOGY_EXACT · 6,382 trials mapped (1,872 active) | — | — | Endometrial Atypical Hyperplasia/Endometrioid Intraepithelial Neoplasia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00791635active not recruiting Longitudinal Evaluation of Women Undergoing Pelvic Surgery for the Treatment of Gynecologic Cancer · condition mapped ONTOLOGY_EXACT · 6,382 trials mapped (1,872 active) | — | — | Cervical Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01012817Phase 1/Phase 2 · active not recruiting Veliparib and Topotecan Hydrochloride in Treating Patients With Solid Tumors, Relapsed or Refractory Ovarian Cancer, or Primary Peritoneal Cancer · condition mapped CURATED_BROADER · 6,382 trials mapped (1,872 active) | — | — | Fallopian Tube Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03074513Phase 2 · active not recruiting Atezolizumab and Bevacizumab in Treating Patients With Rare Solid Tumors · condition mapped ONTOLOGY_EXACT · 6,382 trials mapped (1,872 active) | — | — | Human Papillomavirus-Related Cervical Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04140526Phase 1/Phase 2 · active not recruiting Safety, PK and Efficacy of ONC-392 in Monotherapy and in Combination of Anti-PD-1 in Advanced Solid Tumors and NSCLC · condition mapped CURATED_EXACT · 6,382 trials mapped (1,872 active) | — | — | Malignant Ovarian Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04575935Phase 3 · recruiting Minimally Invasive Surgery After Neoadjuvant Chemotherapy for the Treatment of Stage IIIC-IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer, LANCE Trial · condition mapped ONTOLOGY_EXACT · 6,382 trials mapped (1,872 active) | — | — | Fallopian Tube Clear Cell Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04723095recruiting Establishing a Tumor Registry for Patients With Neuroendocrine Carcinoma of the Cervix · condition mapped ONTOLOGY_EXACT · 6,382 trials mapped (1,872 active) | — | — | Cervical Large Cell Neuroendocrine Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04977453Phase 1/Phase 2 · recruiting GI-101/GI-101A as a Single Agent or in Combination With Pembrolizumab or Lenvatinib in Advanced Solid Tumors · condition mapped CURATED_EXACT · 6,382 trials mapped (1,872 active) | — | — | Malignant Cervical Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05059444recruiting ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation · condition mapped ONTOLOGY_EXACT · 6,382 trials mapped (1,872 active) | — | — | Fallopian Tube Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05634499Phase 2 · completed A Study of Giredestrant in Participants With Grade 1 Endometrial Cancer · condition mapped CURATED_BROADER · 6,382 trials mapped (1,872 active) | — | — | Malignant Endometrial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05799274Phase 1 · active not recruiting Safety of RAD301 in Healthy Human Volunteers and Patients With Pancreatic Cancer or Other Solid Tumors · condition mapped CURATED_EXACT · 6,382 trials mapped (1,872 active) | — | — | Malignant Cervical Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05858736Phase 1 · completed Safety, PK and Efficacy of AI-061 in Advanced Solid Tumors · condition mapped ALIAS · 6,382 trials mapped (1,872 active) | — | — | Malignant Fallopian Tube Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06263283NA · completed Impact of an Educational Physiotherapy-Yoga Intervention on Perceived Stress in Women Treated With Brachytherapy for Cervical Cancer · condition mapped CURATED_EXACT · 6,382 trials mapped (1,872 active) | — | — | Malignant Cervical Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06303505Phase 1/Phase 2 · recruiting FiH Study to Investigate Safety, PK and Efficacy of the NaPi2b ADC TUB-040 in Patients With PROC or r/r Adenocarcinoma NSCLC · condition mapped CURATED_EXACT · 6,382 trials mapped (1,872 active) | — | — | Malignant Ovarian Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06359431NA · completed A Novel Smart Speculum Versus a Standard Speculum for Easy Visualisation of the Cervix and Performing Remote Cervical Cancer Screening · condition mapped CURATED_EXACT · 6,382 trials mapped (1,872 active) | — | — | Malignant Cervical Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06433219Phase 2 · completed Tuvusertib Combined With Niraparib or Lartesertib in Participants With Epithelial Ovarian Cancer (DDRiver EOC 302) · condition mapped CURATED_EXACT · 6,382 trials mapped (1,872 active) | — | — | Malignant Ovarian Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06674811recruiting Biomarkers of Resiliency In Childhood Cancer Surgery · condition mapped ONTOLOGY_EXACT · 6,382 trials mapped (1,872 active) | — | — | Childhood Malignant Ovarian Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06787612Phase 2 · recruiting Investigation of Ubamatamab Combination Therapy in Adult Participants With Platinum-Resistant Ovarian Cancer · condition mapped CURATED_EXACT · 6,382 trials mapped (1,872 active) | — | — | Malignant Ovarian Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07098182NA · recruiting Contribution of Preserving the Superior Left Colic Artery to the Vascularization of the Descending Colon Prior to Colorectal Anastomosis During Left-Sided or Rectal Resections for Colorectal or Ovarian Cancer. (Revascularisation Colique) · condition mapped CURATED_EXACT · 6,382 trials mapped (1,872 active) | — | — | Malignant Ovarian Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07539844recruiting Study to Assess Prevalence of the Folate Receptor Alpha (FRa) in Adult Female Participants With Ovarian Cancer in Intercontinental (InterCon) Countries · condition mapped CURATED_EXACT · 6,382 trials mapped (1,872 active) | — | — | Malignant Ovarian Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07772869NA · recruiting Uterine Lavage to Detect Ovarian Cancer Risk · condition mapped ONTOLOGY_EXACT · 6,382 trials mapped (1,872 active) | — | — | BRCA Hereditary Ovarian Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04633239Phase 1 · recruiting Testing the Addition of Abemaciclib to Olaparib for Women With Recurrent Ovarian Cancer · condition mapped CURATED_BROADER · 6,382 trials mapped (1,872 active) | — | — | Ovarian High Grade Serous Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05081609Phase 1/Phase 2 · active not recruiting A Study to Investigate Safety and Tolerability of TransCon IL-2 β/γ Alone or in Combination With Pembrolizumab and/or TransCon TLR7/8 Agonist or Other Anticancer Therapies in Adult Participants With Locally Advanced or Metastatic Solid Tumor Malignancies · condition mapped ALIAS · 6,382 trials mapped (1,872 active) | — | — | Platinum-Resistant Ovarian Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05123482Phase 1/Phase 2 · recruiting A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies · condition mapped CURATED_EXACT · 6,382 trials mapped (1,872 active) | — | — | Malignant Ovarian Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05979493Phase 4 · recruiting QL Block in Laparoscopic Myomectomy · condition mapped ALIAS · 6,382 trials mapped (1,872 active) | — | — | Uterine Corpus Leiomyoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06840002Phase 1/Phase 2 · recruiting A Clinical Study of SHR-A1811 Combined With Chemotherapy for Platinum Sensitive Recurrent Ovarian Cancer · condition mapped CURATED_EXACT · 6,382 trials mapped (1,872 active) | — | — | Malignant Ovarian Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06964009Phase 1 · recruiting DT2216 + Paclitaxel in Platinum-Resistant Ovarian Cancer · condition mapped CURATED_EXACT · 6,382 trials mapped (1,872 active) | — | — | Malignant Ovarian Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07065552early Phase 1 · recruiting Tirzepatide in Obesity-Driven Endometrial Cancer · condition mapped CURATED_BROADER · 6,382 trials mapped (1,872 active) | — | — | Malignant Endometrial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07181720Phase 1 · suspended CD70-Targeted CAR-T Therapy in CD70-Positive Advanced Solid Tumors · condition mapped CURATED_EXACT · 6,382 trials mapped (1,872 active) | — | — | Malignant Ovarian Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07546578recruiting Setting Up ctDNA Analysis on Archived Plasma Samples · condition mapped CURATED_EXACT · 6,382 trials mapped (1,872 active) | — | — | Malignant Ovarian Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07743164Phase 3 · not yet recruiting A Clinical Trial of Raludotatug Deruxtecan (R-DXd) With or Without Bevacizumab in Participants With Ovarian Cancer Who Have Progressed During Treatment With PARP-inhibitors Treatment on First Line Maintenance (MK-5909-008/ENGOT-ov107/GOG-3142 / REJOICE-Ovarian05) · condition mapped CURATED_EXACT · 6,382 trials mapped (1,872 active) | — | — | Malignant Ovarian Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07764744NA · not yet recruiting Ovarian Cancer Liquid Biopsy for Early Assessment & Detection in Individuals With BRCA1/2 Pathogenic Variants · condition mapped ONTOLOGY_EXACT · 6,382 trials mapped (1,872 active) | — | — | Serous Tubal Intraepithelial Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07814872not yet recruiting A Preregistered Multi-Cohort Evaluation of the FATHOM AI System for Molecular Testing Prioritization to Support Clinical Trial Enrollment · condition mapped ONTOLOGY_EXACT · 6,382 trials mapped (1,872 active) | — | — | Endometrial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07815704Phase 2 · not yet recruiting Targeting Immune Modulation in High Grade Serous Carcinoma: Combined Effects of Chemotherapy and Atorvastatin · condition mapped CURATED_EXACT · 6,382 trials mapped (1,872 active) | — | — | Malignant Ovarian Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07815873NA · not yet recruiting Gut Microbiome in Patients With Lung and Melanoma Cancer and Intestinal Microbiota in Gynecologic Cancers · condition mapped CURATED_BROADER · 6,382 trials mapped (1,872 active) | — | — | Malignant Endometrial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07815951Phase 1 · not yet recruiting Safety and Diagnostic Performance of 111In-TJD-31 SPECT Imaging in Patients With Solid Tumors · condition mapped PROBABILISTIC · 6,382 trials mapped (1,872 active) | — | — | Endometrial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07816263recruiting Guaraná Supplementation for Cancer-Related Fatigue · condition mapped CURATED_EXACT · 6,382 trials mapped (1,872 active) | — | — | Malignant Cervical Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02101775Phase 2 · active not recruiting Gemcitabine Hydrochloride With or Without WEE1 Inhibitor MK-1775 in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer · condition mapped ONTOLOGY_EXACT · 6,382 trials mapped (1,872 active) | — | — | Ovarian Brenner Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02397083Phase 2 · active not recruiting Levonorgestrel-Releasing Intrauterine System With or Without Everolimus in Treating Patients With Atypical Hyperplasia or Stage IA Grade 1 Endometrial Cancer · condition mapped ALIAS · 6,382 trials mapped (1,872 active) | — | — | Endometrial Atypical Hyperplasia/Endometrioid Intraepithelial Neoplasia | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04683653Phase 1/Phase 2 · suspended Study of Pelvic Hypofractionated Radiotherapy in Endometrial Cancer · condition mapped CURATED_BROADER · 6,382 trials mapped (1,872 active) | — | — | Malignant Endometrial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04865887Phase 2 · recruiting Pembrolizumab and Lenvatinib in Advanced Cervical Cancer · condition mapped CURATED_EXACT · 6,382 trials mapped (1,872 active) | — | — | Malignant Cervical Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04931342Phase 2 · active not recruiting A Study Evaluating the Efficacy and Safety of Biomarker-Driven Therapies in Patients With Persistent or Recurrent Rare Epithelial Ovarian Tumors · condition mapped CURATED_EXACT · 6,382 trials mapped (1,872 active) | — | — | Malignant Ovarian Neoplasm | 1 | Observed | clinicaltrials | graph → |